CHICAGO--(BUSINESS WIRE)--CytoCore, Inc., (OTCBB:CYCR) today announced the release of a comprehensive Crystal Research Associates executive report assessing product development and market potential for the late-stage bio-scientific Company’s suite of diagnostic products, slated for worldwide distribution in the screening and treatment of cervical, uterine and endometrial cancers.
